4//SEC Filing
Vitae Pharmaceuticals, Inc 4
Accession 0001104659-15-023109
CIK 0001157602operating
Filed
Mar 25, 8:00 PM ET
Accepted
Mar 26, 4:32 PM ET
Size
22.0 KB
Accession
0001104659-15-023109
Insider Transaction Report
Form 4
PROSPECT MANAGEMENT CO II LLC
10% Owner
Transactions
- Other
Common Stock
2015-03-24−900,383→ 1,672,140 total(indirect: See Footnote) - Other
Common Stock
2015-03-24+20,357→ 32,584 total(indirect: See Footnote) - Other
Common Stock
2015-03-24+20,357→ 28,237 total(indirect: See Footnote)
Holdings
- 395,799(indirect: See Footnote)
Common Stock
- 0(indirect: See Footnote)
Common Stock
- 0(indirect: See Footnote)
Common Stock
SCHNELL DAVID
10% Owner
Transactions
- Other
Common Stock
2015-03-24+20,357→ 32,584 total(indirect: See Footnote) - Other
Common Stock
2015-03-24+20,357→ 28,237 total(indirect: See Footnote) - Other
Common Stock
2015-03-24−900,383→ 1,672,140 total(indirect: See Footnote)
Holdings
- 395,799(indirect: See Footnote)
Common Stock
- 0(indirect: See Footnote)
Common Stock
- 0(indirect: See Footnote)
Common Stock
PROSPECT VENTURE PARTNERS II LP
10% Owner
Transactions
- Other
Common Stock
2015-03-24−900,383→ 1,672,140 total(indirect: See Footnote) - Other
Common Stock
2015-03-24+20,357→ 32,584 total(indirect: See Footnote) - Other
Common Stock
2015-03-24+20,357→ 28,237 total(indirect: See Footnote)
Holdings
- 0(indirect: See Footnote)
Common Stock
- 0(indirect: See Footnote)
Common Stock
- 395,799(indirect: See Footnote)
Common Stock
PROSPECT MANAGEMENT CO LLC
10% Owner
Transactions
- Other
Common Stock
2015-03-24+20,357→ 32,584 total(indirect: See Footnote) - Other
Common Stock
2015-03-24+20,357→ 28,237 total(indirect: See Footnote) - Other
Common Stock
2015-03-24−900,383→ 1,672,140 total(indirect: See Footnote)
Holdings
- 395,799(indirect: See Footnote)
Common Stock
- 0(indirect: See Footnote)
Common Stock
- 0(indirect: See Footnote)
Common Stock
PROSPECT VENTURE PARTNERS LP
10% Owner
Transactions
- Other
Common Stock
2015-03-24−900,383→ 1,672,140 total(indirect: See Footnote) - Other
Common Stock
2015-03-24+20,357→ 32,584 total(indirect: See Footnote) - Other
Common Stock
2015-03-24+20,357→ 28,237 total(indirect: See Footnote)
Holdings
- 395,799(indirect: See Footnote)
Common Stock
- 0(indirect: See Footnote)
Common Stock
- 0(indirect: See Footnote)
Common Stock
HIRSCH RUSSELL C
10% Owner
Transactions
- Other
Common Stock
2015-03-24−900,383→ 1,672,140 total(indirect: See Footnote) - Other
Common Stock
2015-03-24+20,357→ 32,584 total(indirect: See Footnote) - Other
Common Stock
2015-03-24+20,357→ 28,237 total(indirect: See Footnote)
Holdings
- 0(indirect: See Footnote)
Common Stock
- 395,799(indirect: See Footnote)
Common Stock
- 0(indirect: See Footnote)
Common Stock
Footnotes (13)
- [F1]Represents a pro rata distribution without additional consideration by Prospect Venture Partners II, L.P. ("PVP II").
- [F10]The shares previously reported as held by PVP, as Nominee are now being held directly in each of the Beneficial Owners' names.
- [F11]The reportable securities are owned by PVP, as Nominee. PMC is the general partner of PVP. Schnell is the managing member of PMC. Each of PMC and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
- [F12]The shares previously reported as held by PVP II, as Nominee are now being held directly in each of the Beneficial Owners' names.
- [F13]The reportable securities are owned by PVP II, as Nominee. PMC II is the general partner of PVP II. Hirsch and Schnell are the managing members of PMC II. Each of PMC II, Hirsch and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
- [F2]The reportable securities are owned by PVP II. Prospect Management Co. II, L.L.C. ("PMC II") is the general partner of PVP II. Russell Hirsch ("Hirsch") and David Schnell ("Schnell") are the managing members of PMC II. Each of PMC II, Hirsch and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
- [F3]Acquisition by The Hirsch Living Trust Dated 9/22/2000 ("Hirsch Trust") pursuant to a pro rata distribution without additional consideration by PVP II.
- [F4]Includes 4,347 shares previously held through Prospect Venture Partner, L.P. ("PVP"), as Nominee and 7,880 shares previously held through PVP II, as Nominee that are now held directly by Hirsch Trust.
- [F5]The reportable securities are owned directly by Hirsch Trust. Hirsch is a trustee of Hirsch Trust.
- [F6]Acquisition by David Schnell, Trust 2000 U/L DTD May 26, 2000 ("Schnell Trust") pursuant to a pro rata distribution without additional consideration by PVP II.
- [F7]Includes 7,880 shares previously held through PVP II, as Nominee that are now held directly by Schnell Trust.
- [F8]The reportable securities are owned directly by Schnell Trust. Schnell is a trustee of Schnell Trust.
- [F9]The reportable securities are owned by PVP. Prospect Management Co., L.L.C. ("PMC") is the general partner of PVP. Schnell is the managing member of PMC. Each of PMC and Schnell disclaim beneficial ownership of these securities and this report shall not be deemed an admission that any of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of its pecuniary interest therein.
Documents
Issuer
Vitae Pharmaceuticals, Inc
CIK 0001157602
Entity typeoperating
Related Parties
1- filerCIK 0001157602
Filing Metadata
- Form type
- 4
- Filed
- Mar 25, 8:00 PM ET
- Accepted
- Mar 26, 4:32 PM ET
- Size
- 22.0 KB